Pharmaceuticals

We want to change the way iron deficiency is prevented and treated and have brought to market innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Our ambition is to become the world’s preferred partner in the management of iron deficiency and iron deficiency anaemia. We strive to achieve this partnership by simplifying the treatment, spearheading the improvement of patient safety, and driving the expanded use of high-dose intravenous iron across therapy fields.

Advancing scientific knowledge

We conduct clinical research, including large randomised trials, to expand understanding of iron metabolism and anaemia. Our studies contribute to the global evidence base for intravenous iron therapies.

Monofer®

Ferric derisomaltose 100mg/ml

Diafer® - ferric derisomaltose 50 mg/ml

50 mg/ml solution for injection.

Cosmofer® - low Mw iron dextran

Iron dextran

IRON DEFICIENCY

Iron is essential for carrying and storing oxygen in our blood, for energy production, and for cell growth. Learn about the effects of iron deficiency on our health.

ANAEMIA

Anaemia is more common than you think.

Over 1.9 billion people globally are affected by anaemia, making it one of the most widespread health challenges. It affects men, women, and children in every corner of the world, including high-income countries.

Read more about the prevalence, leading causes, and consequences of anaemia.

All about ANAEMIA
PHARMACOSMOS IS...

A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.

Carbohydrates

We are a leader in the development and production of glucose poly- and oligosaccharides and their derivatives for pharmaceutical, high-tech and medical use.

Animal Health

A leading manufacturer and developer of veterinary injectable iron